Table 3.
Change in blood pressure from baseline to weeks 21 and 34, showing means ± standard deviation.
| Absolute change from baseline | ||||
|---|---|---|---|---|
| Bendrofluazide (n) | Doxazosin (n) | Adjusted treatment difference (95% CI) | P-value | |
| Diastolic (mmHg) | ||||
| Baseline | 97.0±5.72 (82) | 98.0±5.85 (78) | ||
| Week 21 | −12.7±8.00 (65) | −14.3±10.09 (60) | −1.2 (−3.9 to 1.6) | 0.407 |
| Week 34 | −13.4±6.88 (48) | −13.8±7.68 (50) | 0.3 (−2.4 to 3.0) | 0.827 |
| Systolic (mmHg) | ||||
| Baseline | 147.7±13.32 (82) | 150.8±13.67 (78) | ||
| Week 21 | −19.1±13.29 (65) | −18.3±15.05 (60) | 1.5 (−3.1 to 6.1) | 0.519 |
| Week 34 | −19.6±14.74 (48) | −15.2±11.81 (50) | 3.5 (−0.8 to 7.8) | 0.106 |